Van Eck Associates Corp Regeneron Pharmaceuticals, Inc. Transaction History

Van Eck Associates Corp

  • $77.4 Billion
  • Q1 2025

A detailed history of Van Eck Associates Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 55,227 shares of REGN stock, worth $32.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
55,227
Previous 58,533 5.65%
Holding current value
$32.7 Million
Previous $41.7 Million 15.99%
% of portfolio
0.05%
Previous 0.05%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$634.14 - $744.83 $2.1 Million - $2.46 Million
-3,306 Reduced 5.65%
55,227 $35 Million
Q4 2024

Jan 29, 2025
BUY
$701.85 - $1046.91 $278,634 - $415,623
397 Added 0.68%
58,533 $41.7 Million
Q3 2024

Oct 29, 2024
BUY
$1024.09 - $1201.76 $4.86 Million - $5.7 Million
4,742 Added 8.88%
58,136 $54.7 Million
Q2 2024

Jul 31, 2024
SELL
$883.2 - $1071.19 $1.72 Million - $2.08 Million
-1,945 Reduced 3.51%
53,394 $56.1 Million
Q1 2024

Apr 30, 2024
SELL
$902.69 - $993.35 $8.12 Million - $8.94 Million
-8,998 Reduced 13.99%
55,339 $53.3 Million
Q4 2023

Feb 05, 2024
BUY
$775.18 - $881.7 $5.82 Million - $6.62 Million
7,509 Added 13.21%
64,337 $56.5 Million
Q3 2023

Nov 08, 2023
SELL
$692.45 - $844.37 $2.35 Million - $2.86 Million
-3,387 Reduced 5.62%
56,828 $46.8 Million
Q2 2023

Aug 03, 2023
BUY
$700.03 - $830.35 $1.01 Million - $1.2 Million
1,445 Added 2.46%
60,215 $43.3 Million
Q1 2023

May 03, 2023
BUY
$680.49 - $826.97 $4.95 Million - $6.01 Million
7,267 Added 14.11%
58,770 $48.3 Million
Q4 2022

Feb 08, 2023
SELL
$705.89 - $766.39 $10.7 Million - $11.6 Million
-15,153 Reduced 22.73%
51,503 $37.2 Million
Q3 2022

Oct 27, 2022
BUY
$573.97 - $724.32 $1.8 Million - $2.27 Million
3,130 Added 4.93%
66,656 $45.9 Million
Q2 2022

Aug 03, 2022
BUY
$548.35 - $738.84 $257,724 - $347,254
470 Added 0.75%
63,526 $37.6 Million
Q1 2022

May 10, 2022
SELL
$595.12 - $698.43 $1.33 Million - $1.57 Million
-2,242 Reduced 3.43%
63,056 $44 Million
Q4 2021

Jan 26, 2022
BUY
$543.48 - $670.97 $2.6 Million - $3.21 Million
4,787 Added 7.91%
65,298 $41.2 Million
Q3 2021

Nov 03, 2021
SELL
$574.03 - $680.96 $2.92 Million - $3.47 Million
-5,089 Reduced 7.76%
60,511 $36.6 Million
Q2 2021

Aug 10, 2021
BUY
$472.8 - $558.54 $1.73 Million - $2.04 Million
3,649 Added 5.89%
65,600 $36.6 Million
Q1 2021

May 13, 2021
BUY
$446.73 - $548.2 $1.69 Million - $2.07 Million
3,777 Added 6.49%
61,951 $29.3 Million
Q4 2020

Feb 09, 2021
BUY
$478.3 - $607.98 $4.27 Million - $5.43 Million
8,928 Added 18.13%
58,174 $28.1 Million
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $2.38 Million - $2.88 Million
4,369 Added 9.74%
49,246 $27.6 Million
Q2 2020

Aug 10, 2020
BUY
$493.32 - $643.92 $3.69 Million - $4.82 Million
7,489 Added 20.03%
44,877 $28 Million
Q1 2020

May 12, 2020
SELL
$336.18 - $494.43 $4.7 Million - $6.91 Million
-13,966 Reduced 27.2%
37,388 $18.3 Million
Q4 2019

Feb 13, 2020
SELL
$274.13 - $376.51 $294,141 - $403,995
-1,073 Reduced 2.05%
51,354 $19.3 Million
Q3 2019

Nov 08, 2019
BUY
$273.46 - $318.39 $223,143 - $259,806
816 Added 1.58%
52,427 $14.5 Million
Q2 2019

Aug 07, 2019
BUY
$299.6 - $414.82 $1.14 Million - $1.58 Million
3,799 Added 7.95%
51,611 $16.2 Million
Q1 2019

May 13, 2019
SELL
$372.08 - $439.57 $1.95 Million - $2.3 Million
-5,233 Reduced 9.87%
47,812 $19.6 Million
Q4 2018

Feb 12, 2019
SELL
$335.82 - $403.04 $1.99 Million - $2.39 Million
-5,923 Reduced 10.04%
53,045 $19.8 Million
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $285,827 - $332,527
814 Added 1.4%
58,968 $23.8 Million
Q2 2018

Aug 13, 2018
SELL
$284.6 - $344.99 $828,186 - $1 Million
-2,910 Reduced 4.77%
58,154 $20.1 Million
Q1 2018

May 11, 2018
SELL
$315.82 - $393.78 $2.68 Million - $3.34 Million
-8,479 Reduced 12.19%
61,064 $21 Million
Q4 2017

Feb 12, 2018
SELL
$358.63 - $469.95 $1 Million - $1.31 Million
-2,798 Reduced 3.87%
69,543 $26.1 Million
Q3 2017

Nov 09, 2017
BUY
$431.38 - $504.0 $2.35 Million - $2.75 Million
5,454 Added 8.15%
72,341 $32.3 Million
Q2 2017

Aug 11, 2017
BUY
N/A
66,887
66,887 $32.9 Million

Others Institutions Holding REGN

# of Institutions
1,469
Shares Held
85.8M
Call Options Held
1.39M
Put Options Held
1.45M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $63.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email